Bright.md, a leading health care automation company, announced that it closed Series C funding, bringing in strategic investors including Philips Health Technology Ventures, UnityPoint Health Ventures and Concord Health Partners, a healthcare-focused investment firm that has partnered with the American Hospital Association (AHA) on its AHA Innovation Development Fund. Bright.md has raised $16.7 million in its oversubscribed Series C round co-led by B Capital, Seven Peaks Ventures and Concord Health Partners.
Bright.md will use the funding for accelerated market and technology expansion of its suite of care-automation solutions, including their award-winning flagship product, SmartExam™, a capacity-boosting, AI-powered, asynchronous telehealth platform already deployed in leading hospitals and health care systems across the U.S. and Canada. Bright.md’s AI-powered asynchronous virtual care platform enables consumers to quickly share their concerns and symptoms with a health care professional, get a diagnosis and treatment, or be fast-tracked for video, in-person, or specialty care. SmartExam acts like a virtual physician’s assistant, automating 90% of a primary, urgent care, or video visit.
Founded in 2014 and based in Portland, Oregon, Bright.md is a leading health care automation company. With its AI-powered care automation platform, SmartExam™, Bright.md empowers health care professionals to create a virtual front door through which consumers can navigate, be triaged, receive care for hundreds of low-acuity medical conditions or be routed to in-person or video visits.
This was reported by Bright.md on May 27, 2020.